We are live on ! Find out more
TARO

Taro Pharmaceutical Industries Ltd.
TARO

Delisted

TARO was delisted on the 21st of June, 2024.

Back to rankings

66 hedge funds and large institutions have $449M invested in Taro Pharmaceutical Industries Ltd. in 2014 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 22 increasing their positions, 17 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

171% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 7

29% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 17

20% more funds holding

Funds holding: 55 → 66 (+11)

10% more capital invested

Capital invested by funds: $408M → $449M (+$41M)

14% less funds holding in top 10

Funds holding in top 10: 7 → 6 (-1)

Holders
66
Holders Change
+11
Holders Change %
+20%
% of All Funds
1.91%
Holding in Top 10
6
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-14.29%
% of All Funds
0.17%
New
19
Increased
22
Reduced
17
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
RCM
Raging Capital Management
New Jersey
+$7.56M
2
Morgan Stanley
Morgan Stanley
New York
+$6.11M
3
PA
Perceptive Advisors
New York
+$4.4M
4
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$4.26M
5
Renaissance Technologies
Renaissance Technologies
New York
+$3.58M

Top Sellers

1
AIM
Assured Investment Management
New York
-$21.6M
2
GCM
Greywolf Capital Management
New York
-$20.7M
3
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management
California
-$8.13M
4
PCM
PAR Capital Management
Massachusetts
-$3.8M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$2.46M
Name Holding Trade Value Shares
Change 		Change in
Stake
HHC
26
Hutchin Hill Capital
New York
$1.11M +$806K +7,400 +285%
BIM
27
Bogle Investment Management
Massachusetts
$1.03M +$1.01M +9,272 New
Jane Street
28
Jane Street
New York
$1.01M +$988K +9,081 New
Bank of New York Mellon
29
Bank of New York Mellon
New York
$936K +$918K +8,429 New
Charles Schwab
30
Charles Schwab
California
$676K +$663K +6,088 New
PP
31
PDT Partners
New York
$603K +$222K +2,040 +60%
CS
32
Credit Suisse
Switzerland
$545K -$239K -2,195 -31%
State Street
33
State Street
Massachusetts
$517K +$60.4K +555 +14%
Citadel Advisors
34
Citadel Advisors
Florida
$515K +$505K +4,642 New
Janney Montgomery Scott
35
Janney Montgomery Scott
Pennsylvania
$500K -$218K -2,000 -31%
New York State Common Retirement Fund
36
New York State Common Retirement Fund
New York
$495K – – –
MC
37
Menta Capital
California
$484K – – –
CFA
38
Camarda Financial Advisors
Florida
$477K +$468K +4,299 New
VanEck Associates
39
VanEck Associates
New York
$476K +$96.9K +890 +26%
CCMG
40
Clark Capital Management Group
Pennsylvania
$465K +$456K +4,190 New
Invesco
41
Invesco
Georgia
$420K +$411K +3,780 New
JIP
42
Jaffetilchin Investment Partners
Florida
$397K -$451K -4,146 -54%
ARTA
43
A.R.T. Advisors
New York
$392K +$385K +3,535 New
HIM
44
Hillsdale Investment Management
Ontario, Canada
$342K -$23.9K -220 -7%
ACI
45
AMP Capital Investors
Australia
$308K +$305K +2,800 New
Comerica Bank
46
Comerica Bank
Texas
$280K +$327 +3 +0.1%
FSC
47
Fiduciary Services Corp
Georgia
$273K -$32.7K -300 -11%
WAM
48
World Asset Management
Michigan
$269K -$63K -579 -19%
GF
49
Gabelli Funds
New York
$222K +$218K +2,000 New
ZDA
50
Zweig-DiMenna Associates
New York
$222K +$218K +2,000 New
1
2
3

TARO Hedge Fund Activity: Q1 2014 in Review

66 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Taro Pharmaceutical Industries Ltd. (TARO) for Q1 2014, worth a combined $449M — up 10% from $408M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new TARO positions and 7 closed out — a net gain of 12 holders — while 22 added to existing stakes and 17 trimmed.

The largest buyer was Raging Capital Management, adding an estimated $7.56M. The largest seller was Assured Investment Management, cutting an estimated $21.6M.

  • 66 institutional investors held Taro Pharmaceutical Industries Ltd. (TARO) as of Q1 2014, up from 55 in Q4 2013.
  • Funds reported $449M of Taro Pharmaceutical Industries Ltd. stock for Q1 2014, up 10% quarter-over-quarter.
  • 19 funds opened new Taro Pharmaceutical Industries Ltd. positions in Q1 2014 and 7 closed out, a net change of +12 holders.
  • The largest Taro Pharmaceutical Industries Ltd. buyer in Q1 2014 was Raging Capital Management, an estimated $7.56M added.
  • The largest Taro Pharmaceutical Industries Ltd. seller in Q1 2014 was Assured Investment Management, an estimated $21.6M sold.

Based on aggregated 13F filings for Q1 2014.